John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Jack in the Box
JACK
$315M
| $1.23M | ﹤0.01% |
14,414
-58,392
| -80% | -$5.04M |
|
|
ABMD
2002
PUT
DELISTED
Abiomed Inc
ABMD
| $1.23M | ﹤0.01% |
+3,000
| New | +$1.09M |
|
2003
PUT
Akamai
AKAM
$15.6B
| $1.22M | ﹤0.01% |
+16,700
| New | +$1.25M |
|
2004
CALL
Ichor Holdings
ICHR
$2.16B
| $1.22M | ﹤0.01% |
+57,400
| New | +$1.37M |
|
2005
Stepan Co
SCL
$1.42B
| $1.22M | ﹤0.01% |
15,600
-36,895
| -70% | -$2.82M |
|
2006
CALL
Edison International
EIX
$28.6B
| $1.22M | ﹤0.01% |
19,200
-5,400
| -22% | -$337K |
|
2007
Towne Bank
TOWN
$3.47B
| $1.21M | ﹤0.01% |
37,752
-29,726
| -44% | -$923K |
|
2008
First Internet Bancorp
INBK
$246M
| $1.21M | ﹤0.01% |
+35,517
| New | +$1.24M |
|
2009
James River Group Holdings
JRVR
$192M
| $1.21M | ﹤0.01% |
30,661
-7,500
| -20% | -$283K |
|
|
BID
2010
DELISTED
Sotheby's
BID
| $1.2M | ﹤0.01% |
22,123
-88,351
| -80% | -$4.89M |
|
|
ARII
2011
DELISTED
American Railcar Industries, Inc.
ARII
| $1.2M | ﹤0.01% |
30,412
+4,918
| +19% | +$190K |
|
2012
PUT
Ryder
R
$9.58B
| $1.2M | ﹤0.01% |
+16,700
| New | +$1.17M |
|
2013
CALL
Twilio
TWLO
$34.7B
| $1.2M | ﹤0.01% |
+21,400
| New | +$1.06M |
|
2014
CALL
Royal Gold
RGLD
$22.5B
| $1.2M | ﹤0.01% |
12,900
-33,700
| -72% | -$3.02M |
|
2015
PUT
Mercado Libre
MELI
$99.2B
| $1.2M | ﹤0.01% |
4,000
-2,100
| -34% | -$662K |
|
2016
CALL
Under Armour
UAA
$2.2B
| $1.2M | ﹤0.01% |
53,200
-21,500
| -29% | -$425K |
|
|
SYRS
2017
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.2M | ﹤0.01% |
+11,712
| New | +$1.45M |
|
|
RCM
2018
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.2M | ﹤0.01% |
137,643
+84,017
| +157% | +$680K |
|
2019
PUT
Cencora
COR
$62.6B
| $1.19M | ﹤0.01% |
+14,000
| New | +$1.23M |
|
2020
Protagonist Therapeutics
PTGX
$9.73B
| $1.19M | ﹤0.01% |
177,479
+144,679
| +441% | +$1.11M |
|
2021
Pegasystems
PEGA
$5.55B
| $1.19M | ﹤0.01% |
43,444
-782,528
| -95% | -$24M |
|
2022
Financial Institutions
FISI
$802M
| $1.19M | ﹤0.01% |
36,127
-4,709
| -12% | -$151K |
|
2023
Tanger
SKT
$4.4B
| $1.19M | ﹤0.01% |
50,595
+15,851
| +46% | +$349K |
|
2024
PUT
AT&T
T
$177B
| $1.19M | ﹤0.01% |
48,988
-1,711,932
| -97% | -$43M |
|
2025
PUT
SPDR Gold Trust
GLD
$154B
| $1.19M | ﹤0.01% |
+10,000
| New | +$1.24M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.